Endoscopic Instrumentation
    and Medical Imaging Solutions

Contact Us

1-800-388-6445

Investor Relations

     



Mammoview ®

Complete Camera Systems

Cameras & Accessories

Endoscopic Instruments

Illumination

Instrument Handles

Insufflation

Laparoscopic Instruments

Rigid Scopes & Accessories

SteriTAP™

Trocars & Cannulas

Veterinary Instrumentation

Video Carts


Investor Relations

Solos Endoscopy , Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office.

Solos Endoscopy, Inc. Letter to Shareholders (January 2014)

 

 

 

Key Information

Symbol: SNDY

Investor Relations Phone: 1-617-360-9719

Mailing Address:
Solos Endoscopy, Inc.
Boston/Dedham Commerce Park
65 Sprague St.
Boston, MA 02136

Financial Qtr Cycle: Mar 31/Jun 30/ Sep 30/ Dec 31

Fiscal Year End: December 31

 

  Current Operations

Solos' has extensive relationships with contract manufacturers for its current products. It maintains customer service and warehousing at its facility in Boston , MA.

Products

The Company has developed products that have enhanced the ability to perform minimally invasive surgical techniques. Products range from complete video systems to specialized hand held instruments.

Offices

Solos Endoscopy Inc's principal office is located at 65 Sprague St., Boston, MA 02136 USA. Phone: 1-800-388-6445.

 


 
Stock Quotes / Charts


OTC Markets: ( www.otcmarkets.com )
Detail Quote: SNDY
Stock Chart: SNDY
News and Press Releases


Yahoo Finance: (
finance.yahoo.com )
SNDY Summary
Stock Charts: SNDY
Headlines - Press Releases


Bloomberg: (
www.bloomberg.com )
Detailed Quote: SNDY
Stock Charts: SNDY
News and Press Releases


Knobias: (
www.knobias.com )
Knobia SNDY Summary Page

 

 

  Investor FAQs

When was Solos Endoscopy, Inc. incorporated?
Solos Endoscopy, Inc. (Solos Endoscopy) was incorporated April 16, 1986 in Nevada, under the name Solos Endoscopy, Inc.

When did Solos Endoscopy go public?
In April of 2006, Solos Endoscopy announced that the Company has gone public through a merger with ViaDux Healthcare, a public company (VDXH).

Where are Solos Endoscopy's corporate headquarters located?
The company's headquarters are currently located in Boston, MA. When does Solos Endoscopy's fiscal year end?
Solos Endoscopy's fiscal year ends on December 31.

Does Solos Endoscopy, Inc.'s report the company' financial results publicly?
No, currently Solos Endoscopy does not file its financials with the Securities and Exchange Commission ( www.sec.gov ).

What industry is Solos Endoscopy in?
Solos Endoscopy is involved in the following industries: Biotechnology, Medical Devices, Health Care, Research and Science.

What is Solos Endoscopy's primary business?
Solos Endoscopy , Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions. Solos' offers state-of-the-art color video camera systems, minimally invasive surgical instrumentation and accessories.

How do I invest in Solos Endoscopy?
You may purchase Solos Endoscopy's common stock from any NASD member broker/dealer, including discount or online brokerage services.

On what stock exchange is Solos Endoscopy listed?
Solos Endoscopy trades on the Pink Sheets under the symbol SNDY.

What is Solos Endoscopy's CUSIP Number?
834371403

Does Solos Endoscopy pay dividends?
No, all resources are being channeled into product marketing and development.

Who do I contact in case of a lost or missing stock certificate?
Pacific Stock Transfer
4045 South Spencer Street
Suite 403
Las Vegas, NV 89119
Phone: (702) 361-3033
Fax: (702) 433-1973


 

  Financial Information

OTC Markets: ( www.otcmarkets.com )
Detail Quote: SNDY


 

  Press Releases

Jan 10, 2014 Solos Endoscopy Posts Shareholder Update on OTC Markets.com

November 7, 2013 Solos Endoscopy Announces the MammoView® Breast Cancer Global Initiative for 2014

October 17, 2013 Solos Endocsopy Reports Results From Stage 2 of Its ISO 13485 Audit With TUV SUD America

June 12, 2013 Solos Endoscopy and TUV SUD America Schedule Stage 2 ISO 13485 Audit for August 16, 2013

May 15, 2013 Solos Endoscopy Reports Full Year 2012 Results

January 24, 2013 Solos Endoscopy and TUV SUD America Schedule Stage 1 ISO 13485 Audit for February 26, 2013

Jan 16, 2013 Solos Finishes 2012 Strong

January 4, 2013 Solos Management Announces Goals for 2013

December 14, 2012 Solos Sales Increases by More than 53% for the Month of November 2012

November 15, 2012 Solos Reports Book Value of of $2,393,522 for Period Ended September 30, 2012

November 8, 2012 Solos Sales Increase by More than 35% for the Month of October

October 24, 2012 Solos Manufacturer to Conduct New Testing to Increase Sterilization Life for its MammoView®

Sept 27, 2012 Solos Endoscopy Celebrates 25 Years of Quality Innovative HealthCare for the Multi-Billion Dollar Endoscopic Market

August 21, 2012 Solos Endoscopy Retains TUV SUD America to Complete ISO 13485 Certification and Audit

August 16, 2012 Solos Endoscopy Posts Total Assets of $2,426,883 for Period Ending June 30, 2012

July 25, 2012 Solos Endoscopy's Bariatric Instruments Are Now Available

July 13, 2012 Solos Endoscopy Begins Marketing the New SteriTAP(TM) Endoscopic Instrument Line

June 19, 2012 Solos Endoscopy to Expand Internationally its MammoView® Breast Endoscopy Product Line

June 13, 2012 Solos Endoscopy Reduces Inventory Cost and Improves Gross Profit Margin

May 23, 2012 Solos Endoscopy Releases ISO 13485 Certification and CE Mark Schedule

May 16, 2012 Solos Endoscopy Posts Net Profit for First Quarter 2012


 

  Legal - Safe Harbor

This, the Solos Endoscopy, Inc. ( www.solosendoscopy.com ) website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in this website, the words “believe,” “expects,” “intends,” “will,” “anticipates,” “anticipated,” or “may,” and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Except for historical information, all of the statements, expectations and assumptions contained in this website are forward-looking that involve a number of risks and uncertainties, including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies or products; delays in testing and evaluation of products; FDA clearance; business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the ability to attract and obtain adequate financing; the price of the Company's stock; and other factors and risks. The Company takes no obligation to update or correct forward-looking statements or information on this website.


 

Solos Endoscopy, Inc.

Boston/Dedham Commerce Park
65 Sprague Street
Boston, MA 02136

Toll Free: 800-388-6445
Local: 617-360-9700
Fax: 617-360-9740

Home Page

Quality

View Products

Ordering
Find out how to order
our products

Equipment Repair
Information about
common repairs and
product conditioning

About Solos
Our mission, history
and how to reach us

Warranty Information
Read our product
warranty information
and policies

Return Policy
How to return a product

Investor Relations
1-617-360-9719

Solos Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research & development of advanced surgical instruments and diagnostic solutions.

 
   
   
Mission | Privacy
© 2001-2014 Solos Endoscopy, Inc.